Skye Bioscience, Inc. Increase (Decrease) in Accounts Payable
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Accounts Payable of $234.53 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2021-03-02
- Skye Bioscience, Inc. increase (decrease) in accounts payable for the quarter ending 2020-12-31 was -$367.29K.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for the quarter ending 2020-09-30 was -$364.65K, a 373.21% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for the quarter ending 2020-06-30 was $159.02K.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for the quarter ending 2020-03-31 was $807.46K, a 428.84% increase year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for fiscal 2020 was $234.53K, a 88.82% increase from fiscal 2019.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for fiscal 2019 was $124.21K.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for fiscal 2018 was -$85.32K.
- Skye Bioscience, Inc. increase (decrease) in accounts payable for fiscal 2017 was -$173.73K, a 216.37% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$367.29K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$731.94K derived: sum of 2 quarters · filed 2021-03-02 | -$572.93K derived: sum of 3 quarters · filed 2021-03-02 | $234.53K 10-K · filed 2021-03-02 |
| 2020-09-30 | -$364.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$205.63K derived: sum of 2 quarters · filed 2020-11-06 | $601.82K 10-Q · filed 2020-11-06 | $534.70K derived: sum of 4 quarters · filed 2021-03-02 |
| 2020-06-30 | $159.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $966.47K 10-Q · filed 2020-08-13 | $899.35K derived: sum of 3 quarters · filed 2021-03-02 | $1.03M derived: sum of 4 quarters · filed 2021-03-02 |
| 2020-03-31 | $807.46K 10-Q · filed 2020-05-08 | $740.34K derived: sum of 2 quarters · filed 2021-03-02 | $873.81K derived: sum of 3 quarters · filed 2021-03-02 | $778.99K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-12-31 | -$67.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $66.35K derived: sum of 2 quarters · filed 2021-03-02 | -$28.47K derived: sum of 3 quarters · filed 2021-03-02 | $124.21K 10-K · filed 2021-03-02 |
| 2019-09-30 | $133.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $38.65K derived: sum of 2 quarters · filed 2020-11-06 | $191.33K 10-Q · filed 2020-11-06 | $161.43K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | -$94.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $57.86K 10-Q · filed 2020-08-13 | $27.96K derived: sum of 3 quarters · filed 2020-08-13 | $61.54K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $152.68K 10-Q · filed 2020-05-08 | $122.78K derived: sum of 2 quarters · filed 2020-05-08 | $156.36K derived: sum of 3 quarters · filed 2020-05-08 | $69.52K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$29.91K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $3.68K derived: sum of 2 quarters · filed 2020-03-23 | -$83.16K derived: sum of 3 quarters · filed 2020-03-23 | -$85.32K 10-K · filed 2020-03-23 |
| 2018-09-30 | $33.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$53.25K derived: sum of 2 quarters · filed 2019-11-14 | -$55.42K 10-Q · filed 2019-11-14 | -$944.62K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$86.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$89.00K 10-Q · filed 2019-08-09 | -$978.20K derived: sum of 3 quarters · filed 2019-08-09 | -$667.57K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$2.16K 10-Q · filed 2019-05-10 | -$891.37K derived: sum of 2 quarters · filed 2019-05-10 | -$580.74K derived: sum of 3 quarters · filed 2019-05-10 | -$128.41K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$889.20K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$578.57K derived: sum of 2 quarters · filed 2019-03-14 | -$126.24K derived: sum of 3 quarters · filed 2019-03-14 | -$173.73K 10-K · filed 2019-03-14 |
| 2017-09-30 | $310.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $762.96K derived: sum of 2 quarters · filed 2018-11-14 | $715.47K 10-Q · filed 2018-11-14 | $602.75K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $452.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $404.84K 10-Q · filed 2018-08-10 | $292.12K derived: sum of 3 quarters · filed 2018-08-10 | $496.28K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | -$47.49K 10-Q · filed 2018-05-15 | -$160.21K derived: sum of 2 quarters · filed 2018-05-15 | $43.95K derived: sum of 3 quarters · filed 2018-05-15 | $89.79K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$112.72K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $91.43K derived: sum of 2 quarters · filed 2018-03-19 | $137.28K derived: sum of 3 quarters · filed 2018-03-19 | $149.29K 10-K · filed 2018-03-19 |
| 2016-09-30 | $204.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $250.00K derived: sum of 2 quarters · filed 2017-11-14 | $262.02K 10-Q · filed 2017-11-14 | $255.14K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $45.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $57.86K 10-Q · filed 2017-08-11 | $50.98K derived: sum of 3 quarters · filed 2017-08-11 | -$102.68K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $12.01K 10-Q · filed 2017-05-12 | $5.13K derived: sum of 2 quarters · filed 2017-05-12 | -$148.53K derived: sum of 3 quarters · filed 2017-05-12 | -$240.74K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$6.88K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$160.54K derived: sum of 2 quarters · filed 2017-03-10 | -$252.75K derived: sum of 3 quarters · filed 2017-03-10 | -$274.14K 10-K · filed 2017-03-10 |
| 2015-09-30 | -$153.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$245.87K derived: sum of 2 quarters · filed 2016-11-09 | -$267.26K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$92.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$113.60K 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | -$21.39K 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $407.34K 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |